These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12117959)

  • 1. Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.
    Chauhan V; Bhatnagar R
    Infect Immun; 2002 Aug; 70(8):4477-84. PubMed ID: 12117959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
    Gupta P; Singh A; Chauhan V; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
    Singh Y; Klimpel KR; Goel S; Swain PK; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1853-9. PubMed ID: 10085027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.
    Cunningham K; Lacy DB; Mogridge J; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
    Moayeri M; Wiggins JF; Leppla SH
    Infect Immun; 2007 Nov; 75(11):5175-84. PubMed ID: 17724066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides.
    Arora N; Leppla SH
    J Biol Chem; 1993 Feb; 268(5):3334-41. PubMed ID: 8429009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
    Singh Y; Klimpel KR; Arora N; Sharma M; Leppla SH
    J Biol Chem; 1994 Nov; 269(46):29039-46. PubMed ID: 7961869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
    Varughese M; Teixeira AV; Liu S; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1860-5. PubMed ID: 10085028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen.
    Brossier F; Sirard JC; Guidi-Rontani C; Duflot E; Mock M
    Infect Immun; 1999 Feb; 67(2):964-7. PubMed ID: 9916116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
    Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.
    Chekanov AV; Remacle AG; Golubkov VS; Akatov VS; Sikora S; Savinov AY; Fugere M; Day R; Rozanov DV; Strongin AY
    Arch Biochem Biophys; 2006 Feb; 446(1):52-9. PubMed ID: 16384550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
    Singh Y; Chaudhary VK; Leppla SH
    J Biol Chem; 1989 Nov; 264(32):19103-7. PubMed ID: 2509473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residue histidine 669 is essential for the catalytic activity of Bacillus anthracis lethal factor.
    Cao S; Guo A; Wu G; Liu Z; Chen W; Feng C; Zhang CC; Chen H
    J Bacteriol; 2010 Nov; 192(21):5799-805. PubMed ID: 20833809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
    Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of protease-treated Bacillus anthracis protective antigen.
    Novak JM; Stein MP; Little SF; Leppla SH; Friedlander AM
    J Biol Chem; 1992 Aug; 267(24):17186-93. PubMed ID: 1512256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular model of anthrax toxin translocation into target-cells].
    Noskov AN
    Bioorg Khim; 2014; 40(4):399-404. PubMed ID: 25898749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.